Facebook and St. Jude Medical surge, GNC and AbbVie skid

NEW YORK (AP) - Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq stock market:

NYSE

St. Jude Medical Inc., up $15.84 to $77.79

The heart device maker agreed to be acquired by Abbott Laboratories in a $19.3 billion cash and stock deal.

GNC Holdings Inc., down $10.28 to $25.32

The nutritional supplement company reported weak first-quarter results, including lower vitamin sales.

Hanesbrands Inc., up $1.74 to $29.53

The maker of underwear, T-shirts and socks, said it will buy Pacific Brands, the biggest maker of underwear in Australia.

AbbVie Inc., up 50 cents to $61.20

AbbVie is buying Stemcentrx, which is developing a drug that uses stem cells to treat small cell lung cancer, for $5.8 billion.

Nasdaq

Facebook Inc., up $7.84 to $116.73

The social network hit an all-time high after its first-quarter profit tripled and revenue was stronger than expected.

PayPal Inc., up 6 cents to $40.07

The online payments company's net income and revenue surpassed analyst estimates.

Medivation Inc., $4.12 to $56.17

French drugmaker Sanofi went public with an offer to buy the cancer drug maker for $9.3 billion, or $52.50 per share.

DreamWorks Animation SKG Inc., $7.75 to $39.95

Comcast's NBCUniversal unit agreed to buy the movie studio for $3.55 billion, or $41 a share.